analyst targets

“Humana’s stock trades at a 7.8% discount to the average analyst price target of $299, following a 4.7% one-year return and 33.6% five-year return, with ongoing margin pressures in Medicare Advantage impacting valuation metrics like a trailing P/E of 25.9 and forward P/E of 21.1.” Humana, a leading health insurance provider focused on Medicare Advantage … Read more